Effect of Platelet Antigen Polymorphism on Platelet Inhibition by Aspirin, Clopidogrel, or Their Combination
- 7 February 2006
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 47 (3), 541-546
- https://doi.org/10.1016/j.jacc.2005.09.034
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationThe New England Journal of Medicine, 2001
- Clopidogrel Inhibition of Stent, Graft, and Vascular Thrombogenesis With Antithrombotic Enhancement by Aspirin in Nonhuman PrimatesCirculation, 1998
- The Antiaggregating and Antithrombotic Activity of Clopidogrel Is Potentiated by Aspirin in Several Experimental Models in the RabbitThrombosis and Haemostasis, 1998
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesThe New England Journal of Medicine, 1992
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988
- Platelet Activation in Unstable Coronary DiseaseThe New England Journal of Medicine, 1986